Pharmaceutical Technology51m
Sanofi’s $17bn sale of Opella to US investors advances following government deal
A stake by France-owned Bpifrance and promise of local job retention have allayed political backlash over the sale of ...
Drug Store News14h
Sanofi, CD&R partner to support Opella’s growth in consumer health care
Sanofi and CD&R are joining forces to fuel Opella’s ambitions as a French-headquartered, global consumer healthcare champion. Sanofi and CD&R have entered exclusive negotiations for the ...
Sanofi Pursues Sale Of Painkiller After Political Controversy
Sanofi confirmed on Monday plans to sell a controlling stake in its over-the-counter unit to a US investment fund, ...
cnbctv182h
Sanofi to sell 50% of Opella in $17 billion deal with CD&R, job guarantees for France included
Sanofi, which is joining a growing number of drugmakers shedding consumer related businesses, said Opella had been valued at ...
Sanofi Engages In Exclusive Talks With US Private Equity CD&R For Its Consumer Health Business
Sanofi SA (NASDAQ:SNY) and private equity Clayton Dubilier & Rice (CD&R) have finally entered into exclusive negotiations to ...
PharmiWeb6h
Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare
Sanofi and CD&R announce today a plan to join forces to fuel Opella’s ambitions as a French-headquartered, global consumer ...
Sanofi confirms €16 billion sale of painkiller Doliprane to US investors
French pharamceutical giant Sanofi has confirmed plans to sell a controlling stake in its over-the-counter unit to a US ...
CD&R Launches Rs 2,983 Crore Open Offer for 26% Stake in Sanofi Consumer Healthcare India
An international investment company, CD&R, has announced plans to acquire a 26% stake in Sanofi Consumer Healthcare India Ltd ...
Press Release: Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare
Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcareSanofi and CD&R enter exclusive negotiations to transfer a 50% ...